{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:16:26Z","timestamp":1793834186737,"version":"4.6.1"},"reference-count":151,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>miRNA-93 is a member of the miR-106b-25 family and is encoded by a gene on chromosome 7q22.1. They play a role in the etiology of various diseases, including cancer, Parkinson\u2019s disease, hepatic injury, osteoarthritis, acute myocardial infarction, atherosclerosis, rheumatoid arthritis, and chronic kidney disease. Different studies have found that this miRNA has opposing roles in the context of cancer. Recently, miRNA-93 has been downregulated in breast cancer, gastric cancer, colorectal cancer, pancreatic cancer, bladder cancer, cervical cancer, and renal cancer. However, miRNA-93 is up-regulated in a wide variety of malignancies, such as lung, colorectal, glioma, prostate, osteosarcoma, and hepatocellular carcinoma.\u00a0The aim of the current review is to provide an overview of miRNA-93's function in cancer disorder\u00a0progression and non-cancer disorders, with a focus on\u00a0dysregulated signaling pathways.\u00a0We also give an overview of this miRNA's function as a biomarker of prognosis in cancer and emphasize how it contributes to drug resistance based on in vivo, in vitro, and human studies.<\/jats:p>","DOI":"10.1186\/s12964-023-01106-3","type":"journal-article","created":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T10:02:35Z","timestamp":1681898555000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["MiRNA-93: a novel signature in human disorders and drug resistance"],"prefix":"10.1186","volume":"21","author":[{"given":"Bashdar Mahmud","family":"Hussen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snur Rasool","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Fatih","family":"Rasul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zanko Hassan","family":"Jawhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goran Sedeeq Hama","family":"Faraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arda","family":"Kiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Taheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,19]]},"reference":[{"key":"1106_CR1","doi-asserted-by":"publisher","first-page":"111528","DOI":"10.1016\/j.biopha.2021.111528","volume":"138","author":"BM Hussen","year":"2021","unstructured":"Hussen BM, Hidayat HJ, Salihi A, Sabir DK, Taheri M, Ghafouri-Fard S. MicroRNA: a signature for cancer progression. Biomed Pharmacother. 2021;138:111528.","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"1106_CR2","doi-asserted-by":"publisher","first-page":"e54789","DOI":"10.15252\/embr.202254789","volume":"23","author":"C Dozier","year":"2022","unstructured":"Dozier C, Plaza S. Functions of animal microRNA-encoded peptides: the race is on! EMBO reports. 2022;23(5):e54789.","journal-title":"EMBO reports."},{"issue":"23","key":"1106_CR3","doi-asserted-by":"publisher","first-page":"5748","DOI":"10.3390\/cancers14235748","volume":"14","author":"LA de Rooij","year":"2022","unstructured":"de Rooij LA, Mastebroek DJ, Ten Voorde N, van der Wall E, van Diest PJ, Moelans CB. The microRNA Lifecycle in Health and Cancer. Cancers. 2022;14(23):5748.","journal-title":"Cancers"},{"key":"1106_CR4","doi-asserted-by":"crossref","unstructured":"Vilimova M, Pfeffer S. Post\u2010transcriptional regulation of polycistronic microRNAs. Wiley Interdisciplinary Reviews: RNA. 2023;14(2):e1749.","DOI":"10.1002\/wrna.1749"},{"issue":"4","key":"1106_CR5","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrm2868","volume":"11","author":"M Inui","year":"2010","unstructured":"Inui M, Martello G, Piccolo S. MicroRNA control of signal transduction. Nat Rev Mol Cell Biol. 2010;11(4):252\u201363.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1106_CR6","doi-asserted-by":"crossref","unstructured":"Shi X, Yang H, Birchler JA. MicroRNAs play regulatory roles in genomic balance. BioEssays. 2023;45(2):2200187.","DOI":"10.1002\/bies.202200187"},{"key":"1106_CR7","doi-asserted-by":"crossref","unstructured":"Olcum M, Tufekci KU, Genc S. MicroRNAs in genetic etiology of human diseases. miRNomics: MicroRNA Biology and Computational Analysis. 2022. pp. 255-68.","DOI":"10.1007\/978-1-0716-1170-8_13"},{"issue":"6","key":"1106_CR8","first-page":"9896","volume":"15","author":"S Fang","year":"2018","unstructured":"Fang S, Gao M, Xiong S, Chen Q, Zhang H. Expression of serum Hsa-miR-93 in uterine cancer and its clinical significance. Oncol Lett. 2018;15(6):9896\u2013900.","journal-title":"Oncol Lett"},{"issue":"11-12","key":"1106_CR9","doi-asserted-by":"publisher","first-page":"194406","DOI":"10.1016\/j.bbagrm.2019.07.007","volume":"1862","author":"R Sperling","year":"2019","unstructured":"Sperling R. Small non-coding RNA within the endogenous spliceosome and alternative splicing regulation. Biochim Biophys Acta Gene Regul Mech. 2019;1862(11\u201312):194406.","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"issue":"20","key":"1106_CR10","doi-asserted-by":"publisher","first-page":"8191","DOI":"10.1158\/0008-5472.CAN-08-1768","volume":"68","author":"F Petrocca","year":"2008","unstructured":"Petrocca F, Vecchione A, Croce CM. Emerging role of miR-106b-25\/miR-17-92 clusters in the control of transforming growth factor \u03b2 signaling. Can Res. 2008;68(20):8191\u20134.","journal-title":"Can Res"},{"key":"1106_CR11","doi-asserted-by":"publisher","first-page":"10507","DOI":"10.1007\/s13277-016-4937-x","volume":"37","author":"R Zhang","year":"2016","unstructured":"Zhang R, Li F, Wang W, Wang X, Li S, Liu J. The effect of antisense inhibitor of miRNA 106b\u223c 25 on the proliferation, invasion, migration, and apoptosis of gastric cancer cell. Tumor Biology. 2016;37:10507\u201315.","journal-title":"Tumor Biology"},{"issue":"5","key":"1106_CR12","doi-asserted-by":"publisher","first-page":"e2796-e","DOI":"10.1038\/cddis.2017.119","volume":"8","author":"N Li","year":"2017","unstructured":"Li N, Miao Y, Shan Y, Liu B, Li Y, Zhao L, et al. MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K\/Akt pathway in breast cancer. Cell Death Dis. 2017;8(5):e2796-e.","journal-title":"Cell Death Dis"},{"key":"1106_CR13","doi-asserted-by":"publisher","first-page":"5645","DOI":"10.1007\/s13277-015-4328-8","volume":"37","author":"M-H Qu","year":"2016","unstructured":"Qu M-H, Han C, Srivastava AK, Cui T, Zou N, Gao Z-Q, et al. miR-93 promotes TGF-\u03b2-induced epithelial-to-mesenchymal transition through downregulation of NEDD4L in lung cancer cells. Tumor Biology. 2016;37:5645\u201351.","journal-title":"Tumor Biology"},{"issue":"2","key":"1106_CR14","doi-asserted-by":"publisher","first-page":"722","DOI":"10.3892\/ol.2016.5463","volume":"13","author":"SJ Wang","year":"2017","unstructured":"Wang SJ, Cao YF, Yang ZQ, Jiang ZY, Cai B, Guo J, et al. MicroRNA-93-5p increases multidrug resistance in human colorectal carcinoma cells by downregulating cyclin dependent kinase inhibitor 1A gene expression. Oncol Lett. 2017;13(2):722\u201330.","journal-title":"Oncol Lett"},{"key":"1106_CR15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.omto.2018.08.001","volume":"11","author":"J-J Liu","year":"2018","unstructured":"Liu J-J, Zhang X, Wu X-H. miR-93 promotes the growth and invasion of prostate cancer by upregulating its target genes TGFBR2, ITGB8, and LATS2. Mol Ther Oncolytics. 2018;11:14\u20139.","journal-title":"Mol Ther Oncolytics"},{"issue":"5","key":"1106_CR16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41389-020-0227-y","volume":"9","author":"E Vila-Navarro","year":"2020","unstructured":"Vila-Navarro E, Fernandez-Casta\u00f1er E, Rovira-Rigau M, Raimondi G, Vila-Casadesus M, Lozano JJ, et al. MiR-93 is related to poor prognosis in pancreatic cancer and promotes tumor progression by targeting microtubule dynamics. Oncogenesis. 2020;9(5):43.","journal-title":"Oncogenesis"},{"issue":"5","key":"1106_CR17","doi-asserted-by":"publisher","first-page":"E729","DOI":"10.1210\/jc.2014-3827","volume":"100","author":"L Jiang","year":"2015","unstructured":"Jiang L, Huang J, Li L, Chen Y, Chen X, Zhao X, et al. MicroRNA-93 promotes ovarian granulosa cells proliferation through targeting CDKN1A in polycystic ovarian syndrome. J Clin Endocrinol Metab. 2015;100(5):E729\u201338.","journal-title":"J Clin Endocrinol Metab"},{"issue":"63","key":"1106_CR18","doi-asserted-by":"publisher","first-page":"107033","DOI":"10.18632\/oncotarget.22300","volume":"8","author":"L Liang","year":"2017","unstructured":"Liang L, Zhao L, Zan Y, Zhu Q, Ren J, Zhao X. MiR-93-5p enhances growth and angiogenesis capacity of HUVECs by down-regulating EPLIN. Oncotarget. 2017;8(63):107033.","journal-title":"Oncotarget"},{"issue":"7","key":"1106_CR19","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/onc.2010.465","volume":"30","author":"L Fang","year":"2011","unstructured":"Fang L, Deng Z, Shatseva T, Yang J, Peng C, Du W, et al. MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-\u03b28. Oncogene. 2011;30(7):806\u201321.","journal-title":"Oncogene"},{"issue":"6","key":"1106_CR20","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1111\/cas.14423","volume":"111","author":"N Shibuya","year":"2020","unstructured":"Shibuya N, Kakeji Y, Shimono Y. MicroRNA-93 targets WASF3 and functions as a metastasis suppressor in breast cancer. Cancer Sci. 2020;111(6):2093\u2013103.","journal-title":"Cancer Sci"},{"issue":"6","key":"1106_CR21","doi-asserted-by":"publisher","first-page":"5313","DOI":"10.3892\/mmr.2020.11594","volume":"22","author":"Y Meng","year":"2020","unstructured":"Meng Y, Qiu S, Sun L, Zuo J. Knockdown of exosome-mediated lnc-PVT1 alleviates lipopolysaccharide-induced osteoarthritis progression by mediating the HMGB1\/TLR4\/NF-\u03baB pathway via miR-93-5p. Mol Med Rep. 2020;22(6):5313\u201325.","journal-title":"Mol Med Rep"},{"issue":"1","key":"1106_CR22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ejr.2020.06.004","volume":"43","author":"ZB Celik","year":"2021","unstructured":"Celik ZB, Tural S, Cengiz AK, Kara N, Alayli G. Upregulation of microRNA-93-5p\/microRNA-4668-5p, and promoter methylation of matrix metalloproteinase-3 and interleukin-16 genes in Turkish patients with rheumatoid arthritis. The Egyptian Rheumatologist. 2021;43(1):35\u20139.","journal-title":"The Egyptian Rheumatologist"},{"issue":"1","key":"1106_CR23","first-page":"674","volume":"8","author":"Y He","year":"2015","unstructured":"He Y, Lin L, Cao J, Mao X, Qu Y, Xi B. Up-regulated miR-93 contributes to coronary atherosclerosis pathogenesis through targeting ABCA1. Int J Clin Exp Med. 2015;8(1):674.","journal-title":"Int J Clin Exp Med"},{"issue":"3","key":"1106_CR24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.mad.2010.12.004","volume":"132","author":"N Li","year":"2011","unstructured":"Li N, Muthusamy S, Liang R, Sarojini H, Wang E. Increased expression of miR-34a and miR-93 in rat liver during aging, and their impact on the expression of Mgst1 and Sirt1. Mech Ageing Dev. 2011;132(3):75\u201385.","journal-title":"Mech Ageing Dev"},{"issue":"7","key":"1106_CR25","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1007\/s11064-021-03333-x","volume":"46","author":"X Wang","year":"2021","unstructured":"Wang X, Liu Z, Wang F. MicroRNA-93 Blocks Signal Transducers and Activator of Transcription 3 to Reduce Neuronal Damage in Parkinson\u2019s Disease. Neurochem Res. 2021;46(7):1859\u201368.","journal-title":"Neurochem Res"},{"issue":"1","key":"1106_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12872-020-01522-0","volume":"20","author":"J Lv","year":"2020","unstructured":"Lv J, Zhu Y, Yao S. LncRNAMORT is upregulated in myocardial infarction and promotes the apoptosis of cardiomyocyte by downregulating miR-93. BMC Cardiovasc Disord. 2020;20(1):1\u20137.","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"1106_CR27","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s11255-021-02907-6","volume":"54","author":"J Peng","year":"2022","unstructured":"Peng J, Qin C, Tian S-Y, Peng J-Q. MiR-93 inhibits the vascular calcification of chronic renal failure by suppression of Wnt\/\u03b2-catenin pathway. Int Urol Nephrol. 2022;54(1):225\u201335.","journal-title":"Int Urol Nephrol"},{"issue":"3","key":"1106_CR28","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ejr.2016.01.001","volume":"38","author":"S Fadda","year":"2016","unstructured":"Fadda S, Abolkheir E, Afifi R, Gamal M. Serum matrix metalloproteinase-3 in rheumatoid arthritis patients: Correlation with disease activity and joint destruction. Egypt Rheumatol. 2016;38(3):153\u20139.","journal-title":"Egypt Rheumatol"},{"issue":"3","key":"1106_CR29","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/cpr.12176","volume":"48","author":"W Jing","year":"2015","unstructured":"Jing W, Jiang W. MicroRNA-93 regulates collagen loss by targeting MMP3 in human nucleus pulposus cells. Cell Prolif. 2015;48(3):284\u201392.","journal-title":"Cell Prolif"},{"issue":"3","key":"1106_CR30","first-page":"310","volume":"51","author":"Y Wu","year":"2021","unstructured":"Wu Y, Xu W, Yang Y, Zhang Z. miRNA-93-5p promotes gemcitabine resistance in pancreatic cancer cells by targeting the PTEN-mediated PI3K\/Akt signaling pathway. Ann Clin Lab Sci. 2021;51(3):310\u201320.","journal-title":"Ann Clin Lab Sci"},{"issue":"9","key":"1106_CR31","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.febslet.2012.03.006","volume":"586","author":"X Fu","year":"2012","unstructured":"Fu X, Tian J, Zhang L, Chen Y, Hao Q. Involvement of microRNA-93, a new regulator of PTEN\/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells. FEBS Lett. 2012;586(9):1279\u201386.","journal-title":"FEBS Lett"},{"issue":"4","key":"1106_CR32","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.3892\/or.2017.5859","volume":"38","author":"S Chu","year":"2017","unstructured":"Chu S, Liu G, Xia P, Chen G, Shi F, Yi T, et al. miR-93 and PTEN: Key regulators of doxorubicin-resistance and EMT in breast cancer. Oncol Rep. 2017;38(4):2401\u20137.","journal-title":"Oncol Rep"},{"issue":"1","key":"1106_CR33","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s13277-014-2611-8","volume":"36","author":"J Hu","year":"2015","unstructured":"Hu J, Xu J, Wu Y, Chen Q, Zheng W, Lu X, et al. Identification of microRNA-93 as a functional dysregulated miRNA in triple-negative breast cancer. Tumor Biology. 2015;36(1):251\u20138.","journal-title":"Tumor Biology"},{"issue":"6","key":"1106_CR34","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.3892\/ijo.2016.3761","volume":"49","author":"S Shyamasundar","year":"2016","unstructured":"Shyamasundar S, Lim JP, Bay BH. miR-93 inhibits the invasive potential of triple-negative breast cancer cells in vitro via protein kinase WNK1. Int J Oncol. 2016;49(6):2629\u201336.","journal-title":"Int J Oncol"},{"issue":"12","key":"1106_CR35","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.7150\/ijbs.36995","volume":"15","author":"S Feng","year":"2019","unstructured":"Feng S, Gao L, Zhang D, Tian X, Kong L, Shi H, et al. MiR-93 regulates vascular smooth muscle cell proliferation, and neointimal formation through targeting Mfn2. Int J Biol Sci. 2019;15(12):2615.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"1106_CR36","doi-asserted-by":"publisher","first-page":"e011134","DOI":"10.1136\/heartasia-2018-011134","volume":"11","author":"JF O'Sullivan","year":"2019","unstructured":"O\u2019Sullivan JF, Neylon A, Fahy EF, Yang P, McGorrian C, Blake GJ. MiR-93-5p is a novel predictor of coronary in-stent restenosis. Heart Asia. 2019;11(1):e011134.","journal-title":"Heart Asia"},{"issue":"12","key":"1106_CR37","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.7150\/ijbs.36995","volume":"15","author":"S Feng","year":"2019","unstructured":"Feng S, Gao L, Zhang D, Tian X, Kong L, Shi H, et al. MiR-93 regulates vascular smooth muscle cell proliferation, and neointimal formation through targeting Mfn2. Int J Biol Sci. 2019;15(12):2615\u201326.","journal-title":"Int J Biol Sci"},{"key":"1106_CR38","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.omtn.2020.11.017","volume":"23","author":"X Feng","year":"2021","unstructured":"Feng X, Zhou S, Cai W, Guo J. The miR-93-3p\/ZFP36L1\/ZFX axis regulates keratinocyte proliferation and migration during skin wound healing. Molecular Therapy-Nucleic Acids. 2021;23:450\u201363.","journal-title":"Molecular Therapy-Nucleic Acids"},{"issue":"8","key":"1106_CR39","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1093\/carcin\/bgs166","volume":"33","author":"I-P Yang","year":"2012","unstructured":"Yang I-P, Tsai H-L, Hou M-F, Chen K-C, Tsai P-C, Huang S-W, et al. MicroRNA-93 inhibits tumor growth and early relapse of human colorectal cancer by affecting genes involved in the cell cycle. Carcinogenesis. 2012;33(8):1522\u201330.","journal-title":"Carcinogenesis"},{"key":"1106_CR40","doi-asserted-by":"publisher","first-page":"626620","DOI":"10.3389\/fonc.2021.626620","volume":"11","author":"Q Li","year":"2021","unstructured":"Li Q, Yue W, Li M, Jiang Z, Hou Z, Liu W, et al. Downregulating long Non-coding RNAs CTBP1-AS2 inhibits colorectal cancer development by modulating the miR-93-5p\/TGF-\u03b2\/SMAD2\/3 pathway. Front Oncol. 2021;11:626620.","journal-title":"Front Oncol"},{"issue":"4","key":"1106_CR41","doi-asserted-by":"publisher","first-page":"5645","DOI":"10.1007\/s13277-015-4328-8","volume":"37","author":"M-H Qu","year":"2016","unstructured":"Qu M-H, Han C, Srivastava AK, Cui T, Zou N, Gao Z-Q, et al. miR-93 promotes TGF-\u03b2-induced epithelial-to-mesenchymal transition through downregulation of NEDD4L in lung cancer cells. Tumor Biology. 2016;37(4):5645\u201351.","journal-title":"Tumor Biology"},{"issue":"1","key":"1106_CR42","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.yexcr.2017.05.007","volume":"357","author":"Y Xiang","year":"2017","unstructured":"Xiang Y, Liao X-H, Yu C-X, Yao A, Qin H, Li J-P, et al. MiR-93-5p inhibits the EMT of breast cancer cells via targeting MKL-1 and STAT3. Exp Cell Res. 2017;357(1):135\u201344.","journal-title":"Exp Cell Res"},{"issue":"8","key":"1106_CR43","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1158\/1541-7786.MCR-08-0507","volume":"7","author":"L Du","year":"2009","unstructured":"Du L, Schageman JJ, Subauste MC, Saber B, Hammond SM, Prudkin L, et al. miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1. Mol Cancer Res. 2009;7(8):1234\u201343.","journal-title":"Mol Cancer Res"},{"key":"1106_CR44","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.gene.2018.01.024","volume":"647","author":"W Yang","year":"2018","unstructured":"Yang W, Bai J, Liu D, Wang S, Zhao N, Che R, et al. MiR-93-5p up-regulation is involved in non-small cell lung cancer cells proliferation and migration and poor prognosis. Gene. 2018;647:13\u201320.","journal-title":"Gene"},{"issue":"34","key":"1106_CR45","doi-asserted-by":"publisher","first-page":"4307","DOI":"10.1038\/onc.2013.381","volume":"33","author":"L Du","year":"2014","unstructured":"Du L, Zhao Z, Ma X, Hsiao T-H, Chen Y, Young E, et al. miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer. Oncogene. 2014;33(34):4307\u201315.","journal-title":"Oncogene"},{"issue":"5","key":"1106_CR46","doi-asserted-by":"publisher","first-page":"870","DOI":"10.7150\/jca.17958","volume":"8","author":"C Li","year":"2017","unstructured":"Li C, Lyu J, Meng QH. MiR-93 promotes tumorigenesis and metastasis of non-small cell lung cancer cells by activating the PI3K\/Akt pathway via inhibition of LKB1\/PTEN\/CDKN1A. J Cancer. 2017;8(5):870.","journal-title":"J Cancer"},{"issue":"3","key":"1106_CR47","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1007\/s13277-015-3949-2","volume":"37","author":"J Shi","year":"2016","unstructured":"Shi J, Jiang X, Yu Z, He G, Ning H, Wu Z, et al. ZNRF3 contributes to the growth of lung carcinoma via inhibiting Wnt\/\u03b2-catenin pathway and is regulated by miR-93. Tumor Biology. 2016;37(3):3051\u20137.","journal-title":"Tumor Biology"},{"issue":"3","key":"1106_CR48","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1002\/jcb.27578","volume":"120","author":"JP Li","year":"2019","unstructured":"Li JP, Xiang Y, Fan LJ, Yao A, Li H, Liao XH. Long noncoding RNA H19 competitively binds miR-93-5p to regulate STAT3 expression in breast cancer. J Cell Biochem. 2019;120(3):3137\u201348.","journal-title":"J Cell Biochem"},{"issue":"23","key":"1106_CR49","doi-asserted-by":"publisher","first-page":"4352","DOI":"10.4161\/cc.22670","volume":"11","author":"L Fang","year":"2012","unstructured":"Fang L, Du WW, Yang W, Rutnam ZJ, Peng C, Li H, et al. MiR-93 enhances angiogenesis and metastasis by targeting LATS2. Cell Cycle. 2012;11(23):4352\u201365.","journal-title":"Cell Cycle"},{"issue":"1","key":"1106_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-019-1507-2","volume":"39","author":"X Chen","year":"2020","unstructured":"Chen X, Liu J, Zhang Q, Liu B, Cheng Y, Zhang Y, et al. Exosome-mediated transfer of miR-93-5p from cancer-associated fibroblasts confer radioresistance in colorectal cancer cells by downregulating FOXA1 and upregulating TGFB3. J Exp Clin Cancer Res. 2020;39(1):1\u201315.","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"1106_CR51","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1007\/s13277-014-2771-6","volume":"36","author":"Q Tang","year":"2015","unstructured":"Tang Q, Zou Z, Zou C, Zhang Q, Huang R, Guan X, et al. MicroRNA-93 suppress colorectal cancer development via Wnt\/\u03b2-catenin pathway downregulating. Tumor Biology. 2015;36(3):1701\u201310.","journal-title":"Tumor Biology"},{"issue":"5","key":"1106_CR52","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1002\/cbin.11323","volume":"44","author":"YL Chen","year":"2020","unstructured":"Chen YL, Wang GX, Lin BA, Huang JS. MicroRNA-93-5p expression in tumor tissue and its tumor suppressor function via targeting programmed death ligand-1 in colorectal cancer. Cell Biol Int. 2020;44(5):1224\u201336.","journal-title":"Cell Biol Int"},{"key":"1106_CR53","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.gene.2018.11.008","volume":"687","author":"H Wei","year":"2019","unstructured":"Wei H, Yang Z, Lin B. Overexpression of long non coding RNA CA3-AS1 suppresses proliferation, invasion and promotes apoptosis via miRNA-93\/PTEN axis in colorectal cancer. Gene. 2019;687:9\u201315.","journal-title":"Gene"},{"issue":"4","key":"1106_CR54","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.bbrc.2018.05.208","volume":"502","author":"X Xue","year":"2018","unstructured":"Xue X, Wang X, Zhao Y, Hu R, Qin L. Exosomal miR-93 promotes proliferation and invasion in hepatocellular carcinoma by directly inhibiting TIMP2\/TP53INP1\/CDKN1A. Biochem Biophys Res Commun. 2018;502(4):515\u201321.","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"1106_CR55","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1007\/s10529-017-2403-5","volume":"39","author":"C Ji","year":"2017","unstructured":"Ji C, Liu H, Yin Q, Li H, Gao H. miR-93 enhances hepatocellular carcinoma invasion and metastasis by EMT via targeting PDCD4. Biotech Lett. 2017;39(11):1621\u20139.","journal-title":"Biotech Lett"},{"key":"1106_CR56","doi-asserted-by":"publisher","first-page":"108871","DOI":"10.1016\/j.abb.2021.108871","volume":"703","author":"J Li","year":"2021","unstructured":"Li J, Zhong X, Wang X, Xu F, Yang J, Lu J, et al. miR-93 regulates liver tumor initiating cells expansion and predicts chemotherapeutic response of patients. Arch Biochem Biophys. 2021;703:108871.","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"1106_CR57","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3390\/genes9010051","volume":"9","author":"X Wang","year":"2018","unstructured":"Wang X, Liao Z, Bai Z, He Y, Duan J, Wei L. MiR-93-5p promotes cell proliferation through down-regulating PPARGC1A in hepatocellular carcinoma cells by bioinformatics analysis and experimental verification. Genes. 2018;9(1):51.","journal-title":"Genes"},{"issue":"5","key":"1106_CR58","doi-asserted-by":"publisher","first-page":"770","DOI":"10.4149\/neo_2017_516","volume":"64","author":"H Huang","year":"2017","unstructured":"Huang H, Wang X, Wang C, Zhuo L, Luo S, Han S. The miR-93 promotes proliferation by directly targeting PDCD4 in hepatocellular carcinoma. Neoplasma. 2017;64(5):770\u20137.","journal-title":"Neoplasma"},{"issue":"35","key":"1106_CR59","doi-asserted-by":"publisher","first-page":"5768","DOI":"10.1038\/s41388-020-01401-0","volume":"39","author":"X Shi","year":"2020","unstructured":"Shi X, Liu T-T, Yu X-N, Balakrishnan A, Zhu H-R, Guo H-Y, et al. microRNA-93-5p promotes hepatocellular carcinoma progression via a microRNA-93-5p\/MAP3K2\/c-Jun positive feedback circuit. Oncogene. 2020;39(35):5768\u201381.","journal-title":"Oncogene"},{"issue":"5","key":"1106_CR60","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.18632\/oncotarget.3085","volume":"6","author":"K Ohta","year":"2015","unstructured":"Ohta K, Hoshino H, Wang J, Ono S, Iida Y, Hata K, et al. MicroRNA-93 activates c-Met\/PI3K\/Akt pathway activity in hepatocellular carcinoma by directly inhibiting PTEN and CDKN1A. Oncotarget. 2015;6(5):3211.","journal-title":"Oncotarget"},{"key":"1106_CR61","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.canlet.2017.08.017","volume":"408","author":"D-H Ma","year":"2017","unstructured":"Ma D-H, Li B-S, Liu J-J, Xiao Y-F, Yong X, Wang S-M, et al. miR-93-5p\/IFNAR1 axis promotes gastric cancer metastasis through activating the STAT3 signaling pathway. Cancer Lett. 2017;408:23\u201332.","journal-title":"Cancer Lett"},{"issue":"1","key":"1106_CR62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0001-8","volume":"6","author":"H Liang","year":"2016","unstructured":"Liang H, Wang F, Chu D, Zhang W, Liao Z, Fu Z, et al. miR-93 functions as an oncomiR for the downregulation of PDCD4 in gastric carcinoma. Sci Rep. 2016;6(1):1\u201311.","journal-title":"Sci Rep"},{"key":"1106_CR63","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.gene.2017.09.071","volume":"641","author":"L Li","year":"2018","unstructured":"Li L, Zhao J, Huang S, Wang Y, Zhu L, Cao Y, et al. MiR-93-5p promotes gastric cancer-cell progression via inactivation of the Hippo signaling pathway. Gene. 2018;641:240\u20137.","journal-title":"Gene"},{"issue":"12","key":"1106_CR64","doi-asserted-by":"publisher","first-page":"e0189490","DOI":"10.1371\/journal.pone.0189490","volume":"12","author":"H Guan","year":"2017","unstructured":"Guan H, Li W, Li Y, Wang J, Li Y, Tang Y, et al. MicroRNA-93 promotes proliferation and metastasis of gastric cancer via targeting TIMP2. PLoS One. 2017;12(12):e0189490.","journal-title":"PLoS One"},{"issue":"1","key":"1106_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-019-1092-7","volume":"20","author":"E Shen","year":"2020","unstructured":"Shen E, Wang X, Liu X, Lv M, Zhang L, Zhu G, et al. MicroRNA-93-5p promotes epithelial-mesenchymal transition in gastric cancer by repressing tumor suppressor AHNAK expression. Cancer Cell Int. 2020;20(1):1\u201313.","journal-title":"Cancer Cell Int"},{"issue":"3","key":"1106_CR66","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1002\/jcb.29469","volume":"121","author":"ZM Liu","year":"2020","unstructured":"Liu ZM, Yang XL, Jiang F, Pan YC, Zhang L. Matrine involves in the progression of gastric cancer through inhibiting miR-93-5p and upregulating the expression of target gene AHNAK. J Cell Biochem. 2020;121(3):2467\u201377.","journal-title":"J Cell Biochem"},{"issue":"5","key":"1106_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41389-020-0227-y","volume":"9","author":"E Vila-Navarro","year":"2020","unstructured":"Vila-Navarro E, Fernandez-Casta\u00f1er E, Rovira-Rigau M, Raimondi G, Vila-Casadesus M, Lozano JJ, et al. MiR-93 is related to poor prognosis in pancreatic cancer and promotes tumor progression by targeting microtubule dynamics. Oncogenesis. 2020;9(5):1\u201314.","journal-title":"Oncogenesis"},{"issue":"59","key":"1106_CR68","doi-asserted-by":"publisher","first-page":"99567","DOI":"10.18632\/oncotarget.20433","volume":"8","author":"Y Cheng","year":"2017","unstructured":"Cheng Y, Yang H, Sun Y, Zhang H, Yu S, Lu Z, et al. RUNX1 promote invasiveness in pancreatic ductal adenocarcinoma through regulating miR-93. Oncotarget. 2017;8(59):99567.","journal-title":"Oncotarget"},{"issue":"1","key":"1106_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-021-08926-x","volume":"21","author":"H Lin","year":"2021","unstructured":"Lin H, Shi X, Li H, Hui J, Liu R, Chen Z, et al. Urinary Exosomal miRNAs as biomarkers of bladder Cancer and experimental verification of mechanism of miR-93-5p in bladder Cancer. BMC Cancer. 2021;21(1):1\u201317.","journal-title":"BMC Cancer"},{"key":"1106_CR70","doi-asserted-by":"crossref","unstructured":"Jiang H, Bu Q, Zeng M, Xia D, Wu A. MicroRNA-93 promotes bladder cancer proliferation and invasion by targeting PEDF. In Urologic oncology: seminars and original investigations. 2019;37(2):150-7.","DOI":"10.1016\/j.urolonc.2018.08.001"},{"key":"1106_CR71","doi-asserted-by":"crossref","unstructured":"Li T, Xu Q, Wei Y, Lin R, Hong Z, Zeng R, Hu W, Wu X. Overexpression of miRNA-93-5p promotes proliferation and migration of bladder urothelial carcinoma via inhibition of KLF9. Comput Math Methods Med. 2022. p. 2022.","DOI":"10.1155\/2022\/8911343"},{"key":"1106_CR72","doi-asserted-by":"crossref","unstructured":"Liu J, Wang Y, Li Z, Pan Y, Liu Q, Yang M, Wang J. Repression of the miR-93-enhanced sensitivity of bladder carcinoma to chemotherapy involves the regulation of LASS2. Onco Targets Ther. 2016. pp. 1813-22.","DOI":"10.2147\/OTT.S97399"},{"issue":"12","key":"1106_CR73","first-page":"5113","volume":"23","author":"X Sun","year":"2019","unstructured":"Sun X, Han X, Zhao X, Cheng X, Zhang Y. MiR-93-5p promotes cervical cancer progression by targeting THBS2\/MMPS signal pathway. Eur Rev Med Pharmacol Sci. 2019;23(12):5113\u201321.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"2","key":"1106_CR74","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s13577-018-00225-1","volume":"32","author":"J Li","year":"2019","unstructured":"Li J, Chu Z-P, Han H, Zhang Y, Tian F, Zhang J-Q, et al. Suppression of miR-93-5p inhibits high-risk HPV-positive cervical cancer progression via targeting of BTG3. Hum Cell. 2019;32(2):160\u201371.","journal-title":"Hum Cell"},{"key":"1106_CR75","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.lfs.2018.08.021","volume":"209","author":"X Zhang","year":"2018","unstructured":"Zhang X, Li F, Zhu L. Clinical significance and functions of microRNA-93\/CDKN1A axis in human cervical cancer. Life Sci. 2018;209:242\u20138.","journal-title":"Life Sci"},{"issue":"2","key":"1106_CR76","doi-asserted-by":"publisher","first-page":"BSR20193794","DOI":"10.1042\/BSR20193794","volume":"40","author":"L Lan","year":"2020","unstructured":"Lan L, Liang Z, Zhao Y, Mo Y. LncRNA MCM3AP-AS1 inhibits cell proliferation in cervical squamous cell carcinoma by down-regulating miRNA-93. Biosci Rep. 2020;40(2):BSR20193794.","journal-title":"Biosci Rep"},{"key":"1106_CR77","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.ijbiomac.2018.12.088","volume":"125","author":"K Yang","year":"2019","unstructured":"Yang K, Li Y-W, Gao Z-Y, Xiao W, Li T-Q, Song W, et al. MiR-93 functions as a tumor promoter in prostate cancer by targeting disabled homolog 2 (DAB2) and an antitumor polysaccharide from green tea (Camellia sinensis) on their expression. Int J Biol Macromol. 2019;125:557\u201365.","journal-title":"Int J Biol Macromol"},{"issue":"10","key":"1106_CR78","doi-asserted-by":"publisher","first-page":"8286","DOI":"10.18632\/oncotarget.3221","volume":"6","author":"L Jiang","year":"2015","unstructured":"Jiang L, Wang C, Lei F, Zhang L, Zhang X, Liu A, et al. miR-93 promotes cell proliferation in gliomas through activation of PI3K\/Akt signaling pathway. Oncotarget. 2015;6(10):8286.","journal-title":"Oncotarget"},{"issue":"6","key":"1106_CR79","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1242\/bio.015552","volume":"5","author":"R Chen","year":"2016","unstructured":"Chen R, Liu H, Cheng Q, Jiang B, Peng R, Zou Q, et al. MicroRNA-93 promotes the malignant phenotypes of human glioma cells and induces their chemoresistance to temozolomide. Biology open. 2016;5(6):669\u201377.","journal-title":"Biology open"},{"issue":"8","key":"1106_CR80","first-page":"2343","volume":"22","author":"D Liu","year":"2018","unstructured":"Liu D, Wei Y, Guo Y, Wang J, Wang G. MiRNA-93 functions as an oncogene in glioma by directly targeting RBL2. Eur Rev Med Pharmacol Sci. 2018;22(8):2343\u201350.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"21","key":"1106_CR81","first-page":"9517","volume":"23","author":"H Wu","year":"2019","unstructured":"Wu H, Liu L, Zhu J. MiR-93-5p inhibited proliferation and metastasis of glioma cells by targeting MMP2. Eur Rev Med Pharmacol Sci. 2019;23(21):9517\u201324.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"1106_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-015-1659-1","volume":"15","author":"E Fabbri","year":"2015","unstructured":"Fabbri E, Brognara E, Montagner G, Ghimenton C, Eccher A, Cant\u00f9 C, et al. Regulation of IL-8 gene expression in gliomas by microRNA miR-93. BMC Cancer. 2015;15(1):1\u201315.","journal-title":"BMC Cancer"},{"issue":"1","key":"1106_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-015-0192-z","volume":"34","author":"M Kawano","year":"2015","unstructured":"Kawano M, Tanaka K, Itonaga I, Ikeda S, Iwasaki T, Tsumura H. microRNA-93 promotes cell proliferation via targeting of PTEN in Osteosarcoma cells. J Exp Clin Cancer Res. 2015;34(1):1\u201311.","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"1106_CR84","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.3892\/etm.2017.4204","volume":"13","author":"Y He","year":"2017","unstructured":"He Y, Yu B. MicroRNA-93 promotes cell proliferation by directly targeting P21 in osteosarcoma cells. Exp Ther Med. 2017;13(5):2003\u201311.","journal-title":"Exp Ther Med"},{"issue":"8","key":"1106_CR85","doi-asserted-by":"publisher","first-page":"BSR20191237","DOI":"10.1042\/BSR20191237","volume":"39","author":"H Zhang","year":"2019","unstructured":"Zhang H, Zhang J, Meng F, Zhu H, Yan H, Guo Y, et al. MicroRNA-93 promotes the tumorigenesis of osteosarcoma by targeting TIMP2. Biosci Rep. 2019;39(8):BSR20191237.","journal-title":"Biosci Rep"},{"issue":"11","key":"1106_CR86","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1007\/s12094-014-1185-7","volume":"16","author":"J Shi","year":"2014","unstructured":"Shi J, Zhuang Y, Liu X, Zhang Y, Zhang Y. TGF-beta induced RBL2 expression in renal cancer cells by down-regulating miR-93. Clin Transl Oncol. 2014;16(11):986\u201392.","journal-title":"Clin Transl Oncol"},{"issue":"3","key":"1106_CR87","first-page":"1","volume":"47","author":"Y Cai","year":"2021","unstructured":"Cai Y, Ruan W, Ding J, Wei N, Wang J, Zhang H, et al. miR-93-5p regulates the occurrence and development of esophageal carcinoma epithelial cells by targeting TGF\u03b2R2. Int J Mol Med. 2021;47(3):1.","journal-title":"Int J Mol Med"},{"issue":"3","key":"1106_CR88","first-page":"171","volume":"31","author":"MX Liu","year":"2018","unstructured":"Liu MX, Juan L, Ming X, Gao ZK, Wang XH, Zhang Y, et al. miR-93-5p transferred by exosomes promotes the proliferation of esophageal cancer cells via intercellular communication by targeting PTEN. Biomed Environ Sci. 2018;31(3):171\u201385.","journal-title":"Biomed Environ Sci"},{"key":"1106_CR89","doi-asserted-by":"publisher","first-page":"117298","DOI":"10.1016\/j.lfs.2020.117298","volume":"244","author":"Z Feng","year":"2020","unstructured":"Feng Z, Chen R, Huang N, Luo C. Long non-coding RNA ASMTL-AS1 inhibits tumor growth and glycolysis by regulating the miR-93-3p\/miR-660\/FOXO1 axis in papillary thyroid carcinoma. Life Sci. 2020;244:117298.","journal-title":"Life Sci"},{"issue":"5","key":"1106_CR90","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1093\/carcin\/bgt026","volume":"34","author":"B Singh","year":"2013","unstructured":"Singh B, Ronghe AM, Chatterjee A, Bhat NK, Bhat HK. MicroRNA-93 regulates NRF2 expression and is associated with breast carcinogenesis. Carcinogenesis. 2013;34(5):1165\u201372.","journal-title":"Carcinogenesis"},{"issue":"1","key":"1106_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-015-0304-6","volume":"14","author":"X Chen","year":"2015","unstructured":"Chen X, Chen S, Xiu Y-L, Sun K-X, Zong Z-H, Zhao Y. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression. Mol Cancer. 2015;14(1):1\u201311.","journal-title":"Mol Cancer"},{"issue":"10","key":"1106_CR92","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1038\/s41374-019-0273-2","volume":"99","author":"Z Wang","year":"2019","unstructured":"Wang Z, Ma K, Cheng Y, Abraham JM, Liu X, Ke X, et al. Synthetic circular multi-miR sponge simultaneously inhibits miR-21 and miR-93 in esophageal carcinoma. Lab Invest. 2019;99(10):1442\u201353.","journal-title":"Lab Invest"},{"issue":"47","key":"1106_CR93","doi-asserted-by":"publisher","first-page":"82824","DOI":"10.18632\/oncotarget.20458","volume":"8","author":"L Wang","year":"2017","unstructured":"Wang L, Yang G, Zhu X, Wang Z, Wang H, Bai Y, et al. miR-93-3p inhibition suppresses clear cell renal cell carcinoma proliferation, metastasis and invasion. Oncotarget. 2017;8(47):82824.","journal-title":"Oncotarget"},{"issue":"13","key":"1106_CR94","first-page":"5657","volume":"23","author":"J Xu","year":"2019","unstructured":"Xu J. MicroRNA-93-5p\/IFNAR1 axis accelerates metastasis of endometrial carcinoma by activating the STAT3 pathway. Eur Rev Med Pharmacol Sci. 2019;23(13):5657\u201366.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"6","key":"1106_CR95","first-page":"5807","volume":"18","author":"Y Cao","year":"2018","unstructured":"Cao Y, Xia F, Wang P, Gao M. MicroRNA-93-5p promotes the progression of human retinoblastoma by regulating the PTEN\/PI3K\/AKT signaling pathway. Mol Med Rep. 2018;18(6):5807\u201314.","journal-title":"Mol Med Rep"},{"issue":"3","key":"1106_CR96","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.bbrc.2019.04.203","volume":"514","author":"C Li","year":"2019","unstructured":"Li C, Wang F, Wei B, Wang L, Kong D. LncRNA AWPPH promotes osteosarcoma progression via activation of Wnt\/\u03b2-catenin pathway through modulating miR-93-3p\/FZD7 axis. Biochem Biophys Res Commun. 2019;514(3):1017\u201322.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1106_CR97","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3892\/ijo.2014.2704","volume":"46","author":"X Xiao","year":"2015","unstructured":"Xiao X, Zhou L, Cao P, Gong H, Zhang Y. MicroRNA-93 regulates cyclin G2 expression and plays an oncogenic role in laryngeal squamous cell carcinoma. Int J Oncol. 2015;46(1):161\u201374.","journal-title":"Int J Oncol"},{"issue":"1","key":"1106_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12672-022-00478-1","volume":"13","author":"G Chen","year":"2022","unstructured":"Chen G, Yan Y, Qiu X, Ye C, Jiang X, Song S, et al. miR-93-5p suppresses ovarian cancer malignancy and negatively regulate CCND2 by binding to its 3\u2032 UTR region. Discover Oncology. 2022;13(1):1\u201311.","journal-title":"Discover Oncology"},{"issue":"13","key":"1106_CR99","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.7150\/jca.43854","volume":"11","author":"S Zhang","year":"2020","unstructured":"Zhang S, He Y, Liu C, Li G, Lu S, Jing Q, et al. miR-93-5p enhances migration and invasion by targeting RGMB in squamous cell carcinoma of the head and neck. J Cancer. 2020;11(13):3871.","journal-title":"J Cancer"},{"issue":"3","key":"1106_CR100","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1097\/MEG.0b013e32835c077a","volume":"25","author":"Z-G Xiao","year":"2013","unstructured":"Xiao Z-G, Deng Z-S, Zhang Y-D, Zhang Y, Huang Z-C. Clinical significance of microRNA-93 downregulation in human colon cancer. Eur J Gastroenterol Hepatol. 2013;25(3):296\u2013301.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"1106_CR101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-018-0552-9","volume":"18","author":"J Hao","year":"2018","unstructured":"Hao J, Jin X, Shi Y, Zhang H. miR-93-5p enhance lacrimal gland adenoid cystic carcinoma cell tumorigenesis by targeting BRMS1L. Cancer Cell Int. 2018;18(1):1\u201312.","journal-title":"Cancer Cell Int"},{"issue":"3","key":"1106_CR102","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1007\/s13277-015-3987-9","volume":"37","author":"MH Ansari","year":"2016","unstructured":"Ansari MH, Irani S, Edalat H, Amin R, Mohammadi RA. Deregulation of miR-93 and miR-143 in human esophageal cancer. Tumor Biology. 2016;37(3):3097\u2013103.","journal-title":"Tumor Biology"},{"issue":"1","key":"1106_CR103","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.jksus.2019.10.006","volume":"32","author":"W Zheng","year":"2020","unstructured":"Zheng W, Yang J, Wang Y, Liu X. Exosomal miRNA-93 and miRNA-205 expression in endometrial cancer. Journal of King Saud University-Science. 2020;32(1):1111\u20135.","journal-title":"Journal of King Saud University-Science"},{"key":"1106_CR104","doi-asserted-by":"publisher","first-page":"5318369","DOI":"10.1155\/2021\/5318369","volume":"2021","author":"C Shi","year":"2021","unstructured":"Shi C, Zhao Y, Li Q, Li J. lncRNA SNHG14 plays a role in sepsis-induced acute kidney injury by regulating miR-93. Mediators Inflamm. 2021;2021:5318369.","journal-title":"Mediators Inflamm"},{"key":"1106_CR105","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.omtn.2018.01.010","volume":"11","author":"J Liu","year":"2018","unstructured":"Liu J, Jiang M, Deng S, Lu J, Huang H, Zhang Y, et al. miR-93-5p-containing exosomes treatment attenuates acute myocardial infarction-induced myocardial damage. Mol Ther Nucleic Acids. 2018;11:103\u201315.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"16","key":"1106_CR106","first-page":"5295","volume":"22","author":"L Xiong","year":"2018","unstructured":"Xiong L, Yu K, Zhen S. MiR-93 blocks STAT3 to alleviate hepatic injury after ischemia-reperfusion. Eur Rev Med Pharmacol Sci. 2018;22(16):5295\u2013304.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"1106_CR107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/JOE-18-0203","volume":"240","author":"Z Wu","year":"2019","unstructured":"Wu Z, Cai L, Lu J, Wang C, Guan J, Chen X, et al. MicroRNA-93 mediates cabergoline resistance by targeting ATG7 in prolactinoma. J Endocrinol. 2019;240(1):1\u201313.","journal-title":"J Endocrinol"},{"issue":"5","key":"1106_CR108","doi-asserted-by":"publisher","first-page":"F1350","DOI":"10.1152\/ajprenal.00254.2019","volume":"317","author":"J Yang","year":"2019","unstructured":"Yang J, Shen Y, Yang X, Long Y, Chen S, Lin X, et al. Silencing of long noncoding RNA XIST protects against renal interstitial fibrosis in diabetic nephropathy via microRNA-93-5p-mediated inhibition of CDKN1A. Am J Physiol Renal Physiol. 2019;317(5):F1350\u20138.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"7","key":"1106_CR109","first-page":"3459","volume":"24","author":"L Qiao","year":"2020","unstructured":"Qiao L, Li C, Liu D. CircRNA_0048211 protects postmenopausal osteoporosis through targeting miRNA-93-5p to regulate BMP2. Eur Rev Med Pharmacol Sci. 2020;24(7):3459\u201366.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"6","key":"1106_CR110","first-page":"5195","volume":"19","author":"X Shu","year":"2019","unstructured":"Shu X, Mao Y, Li Z, Wang W, Chang Y, Liu S, et al. MicroRNA-93 regulates angiogenesis in peripheral arterial disease by targeting CDKN1A. Mol Med Rep. 2019;19(6):5195\u2013202.","journal-title":"Mol Med Rep"},{"issue":"7","key":"1106_CR111","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.2337\/db12-0963","volume":"62","author":"Y-H Chen","year":"2013","unstructured":"Chen Y-H, Heneidi S, Lee J-M, Layman LC, Stepp DW, Gamboa GM, et al. miRNA-93 inhibits GLUT4 and is overexpressed in adipose tissue of polycystic ovary syndrome patients and women with insulin resistance. Diabetes. 2013;62(7):2278\u201386.","journal-title":"Diabetes"},{"issue":"1","key":"1106_CR112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep16890","volume":"5","author":"T Sathyapalan","year":"2015","unstructured":"Sathyapalan T, David R, Gooderham NJ, Atkin SL. Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis. Sci Rep. 2015;5(1):1\u20138.","journal-title":"Sci Rep"},{"issue":"9","key":"1106_CR113","doi-asserted-by":"publisher","first-page":"579","DOI":"10.14740\/jocmr4265","volume":"12","author":"D Tas","year":"2020","unstructured":"Tas D, Kaplan O, Sogut O. Validity of Serum miRNA 93 and miRNA 191 to Reduce Unnecessary Computed Tomography in Patients With Mild Head Trauma. J Clin Med Res. 2020;12(9):579.","journal-title":"J Clin Med Res"},{"issue":"6","key":"1106_CR114","first-page":"631","volume":"27","author":"\u00d6 S\u00f6\u011f\u00fct","year":"2021","unstructured":"S\u00f6\u011f\u00fct \u00d6, Metiner M, Kaplan O, \u00c7al\u0131k M, \u00c7akmak S, \u00dcmit TB, et al. The utility of serum miRNA-93 and miRNA-191 levels for determining injury severity in adults with multiple blunt trauma. Turkish J Trauma Emerg Surg. 2021;27(6):631\u20138.","journal-title":"Turkish J Trauma Emerg Surg"},{"issue":"18","key":"1106_CR115","doi-asserted-by":"publisher","first-page":"10310","DOI":"10.3390\/ijms231810310","volume":"23","author":"A Chaparro","year":"2022","unstructured":"Chaparro A, Lozano M, Gaedechens D, L\u00f3pez C, Albers D, Hern\u00e1ndez M, et al. Exploring the expression of pro-inflammatory and hypoxia-related MicroRNA-20a, MicroRNA-30e, and MicroRNA-93 in periodontitis and gingival mesenchymal stem cells under hypoxia. Int J Mol Sci. 2022;23(18):10310.","journal-title":"Int J Mol Sci"},{"key":"1106_CR116","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.bone.2016.11.016","volume":"95","author":"M Ulbing","year":"2017","unstructured":"Ulbing M, Kirsch A, Leber B, Lemesch S, M\u00fcnzker J, Schweighofer N, et al. MicroRNAs 223\u20133p and 93\u20135p in patients with chronic kidney disease before and after renal transplantation. Bone. 2017;95:115\u201323.","journal-title":"Bone"},{"issue":"1","key":"1106_CR117","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-59142-9","volume":"10","author":"D Niveditha","year":"2020","unstructured":"Niveditha D, Jasoria M, Narayan J, Majumder S, Mukherjee S, Chowdhury R, et al. Common and unique microRNAs in multiple carcinomas regulate similar network of pathways to mediate cancer progression. Sci Rep. 2020;10(1):1\u201311.","journal-title":"Sci Rep"},{"issue":"5","key":"1106_CR118","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1365-2362.2009.02101.x","volume":"39","author":"A B\u00f6hm","year":"2009","unstructured":"B\u00f6hm A, Aichberger KJ, Mayerhofer M, Herrmann H, Florian S, Krauth MT, et al. Targeting of mTOR is associated with decreased growth and decreased VEGF expression in acute myeloid leukaemia cells. Eur J Clin Invest. 2009;39(5):395\u2013405.","journal-title":"Eur J Clin Invest"},{"issue":"8","key":"1106_CR119","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/s41419-020-02855-6","volume":"11","author":"C Bao","year":"2020","unstructured":"Bao C, Chen J, Chen D, Lu Y, Lou W, Ding B, et al. MiR-93 suppresses tumorigenesis and enhances chemosensitivity of breast cancer via dual targeting E2F1 and CCND1. Cell Death Dis. 2020;11(8):618.","journal-title":"Cell Death Dis"},{"issue":"5","key":"1106_CR120","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.119","volume":"8","author":"N Li","year":"2017","unstructured":"Li N, Miao Y, Shan Y, Liu B, Li Y, Zhao L, et al. MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K\/Akt pathway in breast cancer. Cell Death Dis. 2017;8(5): e2796.","journal-title":"Cell Death Dis"},{"issue":"10","key":"1106_CR121","doi-asserted-by":"publisher","first-page":"8286","DOI":"10.18632\/oncotarget.3221","volume":"6","author":"L Jiang","year":"2015","unstructured":"Jiang L, Wang C, Lei F, Zhang L, Zhang X, Liu A, et al. miR-93 promotes cell proliferation in gliomas through activation of PI3K\/Akt signaling pathway. Oncotarget. 2015;6(10):8286\u201399.","journal-title":"Oncotarget"},{"issue":"3","key":"1106_CR122","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1159\/000430270","volume":"36","author":"Q Chen","year":"2015","unstructured":"Chen Q, Qin R, Fang Y, Li H. Berberine Sensitizes Human Ovarian Cancer Cells to Cisplatin Through miR-93\/PTEN\/Akt Signaling Pathway. Cell Physiol Biochem. 2015;36(3):956\u201365.","journal-title":"Cell Physiol Biochem"},{"issue":"8","key":"1106_CR123","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.3390\/ijms21082907","volume":"21","author":"I Nepstad","year":"2020","unstructured":"Nepstad I, Hatfield KJ, Gr\u00f8nnings\u00e6ter IS, Reikvam H. The PI3K-Akt-mTOR Signaling Pathway in Human Acute Myeloid Leukemia (AML) Cells. Int J Mol Sci. 2020;21(8):2907.","journal-title":"Int J Mol Sci."},{"issue":"4","key":"1106_CR124","doi-asserted-by":"publisher","first-page":"5645","DOI":"10.1007\/s13277-015-4328-8","volume":"37","author":"MH Qu","year":"2016","unstructured":"Qu MH, Han C, Srivastava AK, Cui T, Zou N, Gao ZQ, et al. miR-93 promotes TGF-\u03b2-induced epithelial-to-mesenchymal transition through downregulation of NEDD4L in lung cancer cells. Tumour Biol. 2016;37(4):5645\u201351.","journal-title":"Tumour Biol"},{"issue":"12","key":"1106_CR125","doi-asserted-by":"publisher","first-page":"153241","DOI":"10.1016\/j.prp.2020.153241","volume":"216","author":"RV Astamal","year":"2020","unstructured":"Astamal RV, Maghoul A, Taefehshokr S, Bagheri T, Mikaeili E, Derakhshani A, et al. Regulatory role of microRNAs in cancer through Hippo signaling pathway. Pathol Res Pract. 2020;216(12):153241.","journal-title":"Pathol Res Pract"},{"issue":"3","key":"1106_CR126","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1007\/s13277-014-2771-6","volume":"36","author":"Q Tang","year":"2015","unstructured":"Tang Q, Zou Z, Zou C, Zhang Q, Huang R, Guan X, et al. MicroRNA-93 suppress colorectal cancer development via Wnt\/\u03b2-catenin pathway downregulating. Tumour Biol. 2015;36(3):1701\u201310.","journal-title":"Tumour Biol"},{"issue":"2","key":"1106_CR127","doi-asserted-by":"publisher","first-page":"836","DOI":"10.3390\/ijms22020836","volume":"22","author":"R Loveless","year":"2021","unstructured":"Loveless R, Teng Y. Targeting WASF3 signaling in metastatic cancer. Int J Mol Sci. 2021;22(2):836.","journal-title":"Int J Mol Sci"},{"issue":"22","key":"1106_CR128","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1080\/15384101.2019.1670509","volume":"18","author":"Y Shang","year":"2019","unstructured":"Shang Y, Dai S, Chen X, Wen W, Liu X. RETRACTED ARTICLE: MicroRNA-93 regulates the neurological function, cerebral edema and neuronal apoptosis of rats with intracerebral hemorrhage through TLR4\/NF-\u03baB signaling pathway. Cell Cycle. 2019;18(22):3160\u201376.","journal-title":"Cell Cycle"},{"issue":"6","key":"1106_CR129","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1111\/cas.14423","volume":"111","author":"N Shibuya","year":"2020","unstructured":"Shibuya N, Kakeji Y, Shimono Y. MicroRNA-93 targets WASF3 and functions as a metastasis suppressor in breast cancer. Cancer Sci. 2020;111(6):2093\u2013103.","journal-title":"Cancer Sci"},{"issue":"2","key":"1106_CR130","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/path.1706","volume":"205","author":"D Longley","year":"2005","unstructured":"Longley D, Johnston P. Molecular mechanisms of drug resistance. J Pathol. 2005;205(2):275\u201392.","journal-title":"J Pathol"},{"issue":"9","key":"1106_CR131","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.febslet.2012.03.006","volume":"586","author":"X Fu","year":"2012","unstructured":"Fu X, Tian J, Zhang L, Chen Y, Hao Q. Involvement of microRNA-93, a new regulator of PTEN\/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells. FEBS Lett. 2012;586(9):1279\u201386.","journal-title":"FEBS Lett"},{"key":"1106_CR132","doi-asserted-by":"publisher","first-page":"891652","DOI":"10.3389\/fonc.2022.891652","volume":"12","author":"TB Emran","year":"2022","unstructured":"Emran TB, Shahriar A, Mahmud AR, Rahman T, Abir MH, Siddiquee MFR, et al. Multidrug resistance in cancer: understanding molecular mechanisms immunoprevention and therapeutic approaches. Front Oncol. 2022;12:891652.","journal-title":"Front Oncol"},{"key":"1106_CR133","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.brainresbull.2019.03.013","volume":"149","author":"B Hu","year":"2019","unstructured":"Hu B, Mao Z, Du Q, Jiang X, Wang Z, Xiao Z, et al. miR-93-5p targets Smad7 to regulate the transforming growth factor-\u03b21\/Smad3 pathway and mediate fibrosis in drug-resistant prolactinoma. Brain Res Bull. 2019;149:21\u201331.","journal-title":"Brain Res Bull"},{"issue":"3","key":"1106_CR134","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1159\/000430270","volume":"36","author":"Q Chen","year":"2015","unstructured":"Chen Q, Qin R, Fang Y, Li H. Berberine sensitizes human ovarian cancer cells to cisplatin through miR-93\/PTEN\/Akt signaling pathway. Cell Physiol Biochem. 2015;36(3):956\u201365.","journal-title":"Cell Physiol Biochem"},{"issue":"3","key":"1106_CR135","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1136\/gutjnl-2015-309501","volume":"66","author":"V Tovar","year":"2017","unstructured":"Tovar V, Cornella H, Moeini A, Vidal S, Hoshida Y, Sia D, et al. Tumour initiating cells and IGF\/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma. Gut. 2017;66(3):530\u201340.","journal-title":"Gut"},{"issue":"1\u20132","key":"1106_CR136","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.mce.2014.07.014","volume":"395","author":"ZB Wu","year":"2014","unstructured":"Wu ZB, Li WQ, Lin SJ, De Wang C, Cai L, Lu JL, et al. MicroRNA expression profile of bromocriptine-resistant prolactinomas. Mol Cell Endocrinol. 2014;395(1\u20132):10\u20138.","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"1106_CR137","first-page":"4697","volume":"12","author":"J Hu","year":"2019","unstructured":"Hu J, Yi T, Chu S, Zeng H, Xia P, Liu G, et al. DNA methylation of miR-93: an important event in acquiring drug resistance in breast cancer cells. Int J Clin Exp Med. 2019;12(5):4697\u2013706.","journal-title":"Int J Clin Exp Med"},{"issue":"7","key":"1106_CR138","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nrurol.2013.113","volume":"10","author":"H Yoshino","year":"2013","unstructured":"Yoshino H, Seki N, Itesako T, Chiyomaru T, Nakagawa M, Enokida H. Aberrant expression of microRNAs in bladder cancer. Nat Rev Urol. 2013;10(7):396\u2013404.","journal-title":"Nat Rev Urol"},{"key":"1106_CR139","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.ijcard.2016.09.016","volume":"224","author":"F John","year":"2016","unstructured":"John F, Neylon A, McGorrian C, Blake GJ. miRNA-93-5p and other miRNAs as predictors of coronary artery disease and STEMI. Int J Cardiol. 2016;224:310\u20136.","journal-title":"Int J Cardiol"},{"issue":"16","key":"1106_CR140","doi-asserted-by":"publisher","first-page":"26079","DOI":"10.18632\/oncotarget.15317","volume":"8","author":"R Zhang","year":"2017","unstructured":"Zhang R, Guo Y, Ma Z, Ma G, Xue Q, Li F, et al. Long non-coding RNA PTENP1 functions as a ceRNA to modulate PTEN level by decoying miR-106b and miR-93 in gastric cancer. Oncotarget. 2017;8(16):26079.","journal-title":"Oncotarget"},{"issue":"4","key":"1106_CR141","doi-asserted-by":"publisher","first-page":"e1112","DOI":"10.1002\/mgg3.1112","volume":"8","author":"LG Yang","year":"2020","unstructured":"Yang LG, Cao MZ, Zhang J, Li XY, Sun Ql. LncRNA XIST modulates HIF\u20101A\/AXL signaling pathway by inhibiting miR\u201093\u20105p in colorectal cancer. Mol Genetics Genomic Med. 2020;8(4):e1112.","journal-title":"Mol Genetics Genomic Med"},{"issue":"1","key":"1106_CR142","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12890-020-01369-3","volume":"21","author":"W Liu","year":"2021","unstructured":"Liu W, Liang F, Yang G, Xian L. LncRNA LINC01116 sponges miR-93-5p to promote cell invasion and migration in small cell lung cancer. BMC Pulm Med. 2021;21(1):1\u20136.","journal-title":"BMC Pulm Med"},{"issue":"4","key":"1106_CR143","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.3892\/or.2017.5871","volume":"38","author":"L Zhang","year":"2017","unstructured":"Zhang L, Liang X, Li Y. Long non-coding RNA MEG3 inhibits cell growth of gliomas by targeting miR-93 and inactivating PI3K\/AKT pathway Retraction in\/103892\/or. 20207828. Oncol Rep. 2017;38(4):2408\u201316.","journal-title":"Oncol Rep"},{"issue":"4","key":"1106_CR144","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.clinre.2018.11.008","volume":"43","author":"C Chen","year":"2019","unstructured":"Chen C, Zheng Q, Kang W, Yu C. Long non-coding RNA LINC00472 suppresses hepatocellular carcinoma cell proliferation, migration and invasion through miR-93-5p\/PDCD4 pathway. Clin Res Hepatol Gastroenterol. 2019;43(4):436\u201345.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"1106_CR145","doi-asserted-by":"publisher","first-page":"9515","DOI":"10.2147\/CMAR.S257419","volume":"12","author":"K Zhang","year":"2020","unstructured":"Zhang K, Cai Y, Zhou Q, Sun H, Wei J. Long non-coding RNA SNHG14 impedes viability, migration and invasion of endometrial carcinoma cells through modulating miR-93-5p\/ZBTB7A axis. Cancer Manag Res. 2020;12:9515.","journal-title":"Cancer Manag Res"},{"key":"1106_CR146","doi-asserted-by":"crossref","unstructured":"Zhang XY, Zhuang HW, Wang J, Shen Y, Bu YZ, Guan BG, Xu F, Dou J. Long noncoding RNA CA3-AS1 suppresses gastric cancer migration and invasion by sponging miR-93-5p and targeting BTG3. Gene Therapy. 2022;29(9):566-74.","DOI":"10.1038\/s41434-020-00201-1"},{"issue":"11","key":"1106_CR147","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1002\/1878-0261.12565","volume":"13","author":"YJ Li","year":"2019","unstructured":"Li YJ, Yang Z, Wang YY, Wang Y. Long noncoding RNA ZNF667-AS1 reduces tumor invasion and metastasis in cervical cancer by counteracting microRNA-93-3p-dependent PEG3 downregulation. Mol Oncol. 2019;13(11):2375\u201392.","journal-title":"Mol Oncol"},{"key":"1106_CR148","doi-asserted-by":"publisher","first-page":"8855","DOI":"10.2147\/OTT.S182005","volume":"11","author":"F Xu","year":"2018","unstructured":"Xu F, Zha G, Wu Y, Cai W, Ao J. Overexpressing lncRNA SNHG16 inhibited HCC proliferation and chemoresistance by functionally sponging hsa-miR-93. Onco Targets Ther. 2018;11:8855.","journal-title":"Onco Targets Ther"},{"key":"1106_CR149","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.gene.2018.04.069","volume":"671","author":"L Wang","year":"2018","unstructured":"Wang L, Liu S, Mao Y, Xu J, Yang S, Shen H, et al. CircRNF13 regulates the invasion and metastasis in lung adenocarcinoma by targeting miR-93-5p. Gene. 2018;671:170\u20137.","journal-title":"Gene"},{"issue":"5","key":"1106_CR150","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1038\/s41418-019-0455-x","volume":"27","author":"W Huang","year":"2020","unstructured":"Huang W, Yang Y, Wu J, Niu Y, Yao Y, Zhang J, et al. Circular RNA cESRP1 sensitises small cell lung cancer cells to chemotherapy by sponging miR-93-5p to inhibit TGF-\u03b2 signalling. Cell Death Differ. 2020;27(5):1709\u201327.","journal-title":"Cell Death Differ"},{"key":"1106_CR151","doi-asserted-by":"crossref","unstructured":"Shen L, Dang J, Liu S, Xian B, Deng Y, Qu D. CircRNA VPRBP inhibits tumorigenicity of cervical cancer via miR-93-5p\/FRMD6 axis. Reprod Sci. 2022;29(8):2251-64.","DOI":"10.1007\/s43032-022-00923-0"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-023-01106-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-023-01106-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-023-01106-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T16:27:15Z","timestamp":1682353635000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-023-01106-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,19]]},"references-count":151,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1106"],"URL":"https:\/\/doi.org\/10.1186\/s12964-023-01106-3","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,19]]},"assertion":[{"value":"31 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participant"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent of publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"79"}}